Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | A summary of lymphoma immune checkpoint inhibitor data at EHA 2017

Anas Younes, MD, from Memorial Sloan Kettering Cancer Center, NY, USA shares the latest data on immune checkpoint inhibitors presented during the summer congresses; ASCO, ICML and EHA. Included in his wrap up is the CHECKMATE 205 trial with nivolumab and the potential for targeting PDL-1 on which there was a Phase 1 trial presented at ICML. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.